companies-investments-novo-27.html
Novo Annual Review 2016
28 / 71
investments in 2016 novo ventures in brief 2016 venture investments in
dkk
million value at the end of the year investments during the year cash proceeds during the year unrealised and realised returns during the year 5,880 2016 2015 3,854 1,733 759 694 1,959 2,091 3,643
dkk
0.3
billion
in europe
dkk
1.8
billion
in the us 4 ? new public
companies
(1
billion
dkk
invested) 10 ? new private
companies
(1
billion
dkk
invested) 28 novo a/s 2016 novo a/s is one of the largest life science venture capital investors in the world. we currently invest more than
dkk
2
billion
on an annual basis. since 2000, we have invested in 138
companies
, and successfully exited 44
companies
through trade sales and ipos. we have activities in copenhagen, san francisco, boston and london. through our international network of scientific, development and commercial expertise, we cover the major life science hubs. geographical allocation by number of
companies
48% ? clinical 19% ? pre-clinical 93 ? usa 1 (in each) ? austria france netherlands sweden 2 ? canada 6 ? switzerland 14 ? uk 18 ? denmark 10% ? pre-lead medtech capital distribution by initial investment stage drugs 4% ? pre-revenue 19% ? revenue
novo-usd-million-29.html
